Sfoglia per Autore
TNF alpha and hereditary hemocromatosis: Possible interactions
2000 L. Valenti, A.L. Fracanzani, A. Scaccabarozzi, P. Dongiovanni, G. Santorelli, G. Fiorelli, S. Fargion
What is the contribution of differences in three measures of tumor necrosis factor-alpha activity to insulin resistance in healthy volunteers?
2003 I. Zavaroni, F. Numeroso, P. Dongiovanni, D. Ardigò, L. Valenti, A.L. Fracanzani, S. Valtuen̂a, R. Delsignore, S. Fargion, G.M. Reaven
TNF alpha promoter polymorphisms in Italian patients with porphyria cutanea tarda
2003 P. Dongiovanni, L.V.C. Valenti, A.L. Fracanzani, M.D. Cappellini, S.R. Fargion
TNFalpha promoter polymorphisms
2004 S.R. Fargion, L.V.C. Valenti, P. Dongiovanni, A.L. Fracanzani
The mitochondrial superoxide dismutase A16V polymorphism in the cardiomyopathy associated with hereditary haemochromatosis
2004 L. Valenti, D. Conte, A. Piperno, P. Dongiovanni, A. L. Fracanzani, M. Fraquelli, A. Vergani, C. Gianni, L. Carmagnola, S. R. Fargion
Increased prevalence of PIS Alpha1-antitrypsin allele in italian patients with non alcoholic fatty liver disease
2005 L. Valenti, P. Dongiovanni, A. Guzzo, S. Colombo, P. Loria, A. Piperno, A. Casiraghi, E. Ceriani, A.L. Fracanzani, S. Fargion
TNFalpha genotype affects TNFalpha release, insulin sensitivity and the severity of liver disease in HCV chronic hepatitis
2005 L. Valenti, E. Pulixi, A.L. Fracanzani, P. Dongiovanni, M. Maggioni, A. Orsatti, C. Gianni, S. Fargion
Increased prevalence of PIS Alpha1-antitrypsin allele in italian patients with non-alcoholic fatty liver disease
2005 L. Valenti, P. Dongiovanni, S. Guzzo, S. Colombo, P. Loria, A. Piperno, A. Casiraghi, R. Ceriani, A.L. Fracanzani, S. Fargion
Iron and insulin resistance
2005 S.R. Fargion, P. Dongiovanni, A. Guzzo, S. Colombo, L.V.C. Valenti, A.L. Fracanzani
α1-Antitrypsin mutations in NAFLD : high prevalence and association with altered iron metabolism but not with liver damage
2006 L. Valenti, P. Dongiovanni, A. Piperno, A.L. Fracanzani, M. Maggioni, R. Rametta, P. Loria, M.A. Casiraghi, E. Suigo, R. Ceriani, E. Remondini, P. Trombini, S. Fargion
Serum ferritin, is associated with iron availability, decreased anti-oxidant potemtial and HFE gene mutations, and a risk factor for cardiovascular damage in hemodialysis patients
2006 L. Valenti, G. Valenti, G. Como, L. Burdick, G. Santorelli, P. Dongiovanni, A.L. Fracanzani, P.G. Messa, S. Fargion
Iron depletion by phlebotomy improves insulin resistance in patients with non alcoholic fatty liver disease and hyperferritinemia ; evidence from a multicenter case control study
2006 L.V.C. Valenti, E. Remondini, P. Dongiovanni, E. Bugianesi, A.L. Fracanzani, S.R. Fargion
Iron status modulates the expression of the ubiquitin ligase mdm-2 and of its target p53 in mouse hepatocytes and primary human monocytes
2006 L. Valenti, P. Dongiovanni, C. Megazzini, R. Rametta, A.L. Fracanzani, S. Fargion
Increased expression of the forkihead transcription factor foxo1 associated with gluconeogenesis and insulin resistance in non-alcoholic steatohepatitis
2006 L. Valenti, R. Rametta, P. Dongiovanni, A.L. Fracanzani, S. Fargion
Hepatic expression of the forkhead transcription factor foxO1 is increased in non-alcoholic steatohepatitis and associated with gluconeogenesis and insulin resistance
2006 L. Valenti, R. Rametta, A.L. Fracanzani, P. Dongiovanni, S. Fargion
Iron affect glucose metabolismi in hepatocytes by regulating insulin receptor expression and glucose uptake
2006 P. Dongiovanni, L. Valenti, G. Cairo, S. Gatti, A.L. Fracanzani, S. Fargion
Risk of early atherosclerosis evaluated by carotid artery intima-media thickness in patients with non-alcoholic fatty liver disease : a case control study
2006 L. Valenti, R. Rametta, A.L. Fracanzani, P. A Dongiovanni, S. Fargion
Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis
2007 L. Valenti, E.A. Pulixi, P. Arosio, L. Cremonesi, G. Biasiotto, P. Dongiovanni, M. Maggioni, S. Fargion, A.L. Fracanzani
Iron status modulates the expression of the ubiquitin ligase mdm-2 and its target p53 in mouse hepatocytes and human monocytes; effect on the anti-oxidant response in hepatocytes
2007 L. Valenti, P. Dongiovanni, C. Megazzini, A.L. Fracanzani, S. Fargion
Genetic polymorphisms influencing insulin signalling and lipogenesis affect the risk of hepatic fibrosis in patients with nonalcoholic fatty liver disease
2007 P. Dongiovanni, L. Valenti, R. Rametta, A.L. Fracanzani, S. Fargion
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile